Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.53B.
ENTERPRISE VALUE (EV)
$1.53B
Embecta Corp.
Market Cap
$357.28M
Enterprise Value (EV)
$1.53B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Embecta Corp. (EMBC) | $357.28M | $1.53B |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $356.58M | $315.33M |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.92M | $64.32M |
| Relmada Therapeutics, Inc. (RLMD)vs › | $355.58M | $344.24M |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $355.18M | $377.41M |
| Ocugen, Inc. (OCGN)vs › | $359.46M | $347.39M |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $352.32M | $402.61M |
| Opus Genetics, Inc. (IRD)vs › | $364.53M | $310.65M |
| Canopy Growth Corporation (CGC)vs › | $374.87M | $333.13M |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $376.04M | $207.49M |
Market Cap
$357.28M
Total Debt
$1.40B
Cash
$225.50M
Enterprise Value
$1.53B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
